Atlas Trials

Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients

Clinical trial NCT07053358 · RECRUITING

Trial details

NCT number
NCT07053358
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Neovascular Age-related Macular Degeneration
Start date
2025-07-02
Primary completion
2026-11-23
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.